-
Views
-
Cite
Cite
Sung-Han Kim, Ji-Whan Bang, Kyung-Hwa Park, Wan-Bum Park, Hong-Bin Kim, Nam-Joong Kim, Youngmee Jee, Haewol Cho, Myoung-don Oh, Kang-Won Choe, Prediction of Residual Immunity to Smallpox, by Means of an Intradermal Skin Test with Inactivated Vaccinia Virus, The Journal of Infectious Diseases, Volume 194, Issue 3, 1 August 2006, Pages 377–384, https://doi.org/10.1086/505505
- Share Icon Share
Abstract
BackgroundIntradermal skin testing with inactivated vaccinia virus was evaluated for its prediction of residual immunity to smallpox
MethodsAn intradermal skin test was performed with heat-inactivated Lancy-Vaxina. Two days later, the subjects were vaccinated with Lancy-Vaxina. The skin lesions resulting from this vaccination were used as a surrogate marker of residual immunity to smallpox, and this surrogate marker was compared with the available indicators of susceptibility to smallpox
ResultsOf the 83 subjects, 30 (36%) showed the typical primary response after vaccination (i.e., absence of residual immunity), whereas 34 (41%) showed the typical revaccinee’s response (i.e., presence of residual immunity); the remaining 19 (23%) had an indeterminate response and were excluded from the final analysis. The sensitivity and specificity of the intradermal skin test (induration size, ⩾4 mm) for prediction of residual immunity to smallpox were 85% and 97%, respectively, whereas those of a positive vaccinia-specific interferon-γ–producing T cell response (⩾9 spot forming cells/106 peripheral-blood mononuclear cells) were 32% and 63%, respectively, and those of a positive neutralizing antibody (titer, ⩾1:8) were 79% and 80%, respectively
ConclusionThe intradermal skin test appears to be a simple and reliable method for prediction of residual immunity to smallpox